U.S. markets closed

Vigil Neuroscience, Inc. (VIGL)

NasdaqGS - NasdaqGS Precio en tiempo real. Moneda en USD.
Añadir a la lista de seguimiento
3.8600-0.3300 (-7.88%)
Al cierre: 04:00PM EDT
3.8601 +0.00 (+0.00%)
Fuera de horario: 06:02PM EDT

Vigil Neuroscience, Inc.

100 Forge Road
Suite 700 Watertown
Watertown, MA 02472
United States
857 254 4445
https://www.vigilneuro.com

Sector(es)Healthcare
IndustriaBiotechnology
Empleados a tiempo completo65

Descripción

Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Its lead candidate is VGL101(Iluzanebart), a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 and is in a Phase 2 trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. The company is also developing VG-3927, an orally-available small molecule TREM2 agonist to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer's disease in genetically defined subpopulations, which is being evaluated in a Phase 1 clinical trial. It has license agreement with Amgen Inc. to commercially develop, manufacture, use, distribute, and sell therapeutic products containing compounds that bind to TREM2. The company was incorporated in 2020 and is headquartered in Watertown, Massachusetts.

Gestión corporativa

La calificación ISS Governance QuickScore de Vigil Neuroscience, Inc. a partir del 1 de junio de 2024 es 7. Las puntuaciones principales son Auditoría: 7; Junta: 4; Derechos del accionista: 8; Compensación: 9.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.